Report Thumbnail
Product Code LP0914017527T6
Published Date 2026/8/26
English87 PagesGlobal

Global Bacterial Vaginosis (BV) Test Kits Market Growth 2026-2032 ‐ MedicalDevice / MedTech Market


Report Thumbnail
Product Code LP0914017527T6
Published Date 2026/8/26
English 87 PagesGlobal

Global Bacterial Vaginosis (BV) Test Kits Market Growth 2026-2032 ‐ MedicalDevice / MedTech Market



Abstract

This report provides a comprehensive analysis of the global Bacterial Vaginosis (BV) Test Kits market, projecting significant growth through 2032. It examines key market drivers and trends across various segments, including product types like Gardnerella and Anaerobic Vaginitis, and applications such as hospitals and clinics. Detailed regional insights cover the Americas, APAC, Europe, and the Middle East and Africa. Furthermore, the study evaluates competitive landscapes and strategic activities of leading industry players, including Hologic, Bayer, and Sekisui Diagnostics.

Related Questions

Liming Bio, Exeltis USA Inc, Sekisui Diagnostics, Bayer, Hologic, AccuQuik, AtilaBiosystems


Summary

Market Overview

The global Bacterial Vaginosis (BV) Test Kits market is projected to experience significant growth from 2025 through 2032, expanding at a steady compound annual growth rate over the forecast period.

Regional Market Analysis

  • United States: The market for Bacterial Vaginosis (BV) Test Kits in the United States is estimated to increase from 2025 through 2032, maintaining a consistent growth trajectory.
  • China: The market for Bacterial Vaginosis (BV) Test Kits in China is estimated to see upward movement from 2025 to 2032, characterized by a sustained growth rate.
  • Europe: The European market for Bacterial Vaginosis (BV) Test Kits is expected to expand from 2025 through 2032, following a positive growth trend.

Report Scope and Methodology

LP Information, Inc. (LPI)'s newest research report, the “Bacterial Vaginosis (BV) Test Kits Industry Forecast,” examines past sales and reviews total global Bacterial Vaginosis (BV) Test Kits sales in 2025. The report provides a comprehensive analysis by region and market sector of projected Bacterial Vaginosis (BV) Test Kits sales for 2026 through 2032.

With Bacterial Vaginosis (BV) Test Kits sales broken down by region, market sector, and sub-sector, this report provides a detailed analysis in US$ millions of the world Bacterial Vaginosis (BV) Test Kits industry. This Insight Report provides a comprehensive analysis of the global Bacterial Vaginosis (BV) Test Kits landscape and highlights key trends related to:

  • Product segmentation
  • Company formation
  • Revenue and market share
  • Latest developments
  • M&A activity

Furthermore, the report analyzes the strategies of leading global companies with a focus on Bacterial Vaginosis (BV) Test Kits portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Bacterial Vaginosis (BV) Test Kits market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bacterial Vaginosis (BV) Test Kits and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. Using a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study offers a highly nuanced view of the current state and future trajectory in the global Bacterial Vaginosis (BV) Test Kits market. The report presents a comprehensive overview, market shares, and growth opportunities of the Bacterial Vaginosis (BV) Test Kits market by product type, application, key manufacturers, and key regions and countries.

Market Segmentation

By Type

  • Haemophilus Vaginitis
  • Corynebacterium Vaginitis
  • Anaerobic Vaginitis
  • Gardnerella Vaginitis
  • Others

By Application

  • Online Pharmacy
  • Hospital
  • Clinic

By Region

  • Americas
  • United States
  • Canada
  • Mexico
  • Brazil
  • APAC
  • China
  • Japan
  • Korea
  • Southeast Asia
  • India
  • Australia
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
  • Middle East & Africa
  • Egypt
  • South Africa
  • Israel
  • Turkey
  • GCC Countries

Competitive Landscape

The global Bacterial Vaginosis (BV) Test Kits market features several key players. In terms of revenue, the two largest companies occupied a significant portion of the market share in 2025.

The following companies have been profiled based on inputs gathered from primary experts and analysis of their coverage, product portfolio, and market penetration:

  • Liming Bio
  • Exeltis USA Inc
  • Sekisui Diagnostics
  • Bayer
  • Hologic
  • AccuQuik
  • AtilaBiosystems

Key Questions Addressed in this Report

  • What is the 10-year outlook for the global Bacterial Vaginosis (BV) Test Kits market?
  • What factors are driving Bacterial Vaginosis (BV) Test Kits market growth, globally and by region?
  • Which technologies are poised for the fastest growth by market and region?
  • How do Bacterial Vaginosis (BV) Test Kits market opportunities vary by end market size?
  • How does Bacterial Vaginosis (BV) Test Kits break out by Type and by Application?

Table of Contents

  • 1 Scope of the Report

    • 1.1 Market Introduction
    • 1.2 Years Considered
    • 1.3 Research Objectives
    • 1.4 Market Research Methodology
    • 1.5 Research Process and Data Source
    • 1.6 Economic Indicators
    • 1.7 Currency Considered
    • 1.8 Market Estimation Caveats
  • 2 Executive Summary

    • 2.1 World Market Overview
      • 2.1.1 Global Bacterial Vaginosis (BV) Test Kits Annual Sales 2021-2032
      • 2.1.2 World Current & Future Analysis for Bacterial Vaginosis (BV) Test Kits by Geographic Region, 2021, 2025 & 2032
      • 2.1.3 World Current & Future Analysis for Bacterial Vaginosis (BV) Test Kits by Country/Region, 2021, 2025 & 2032
    • 2.2 Bacterial Vaginosis (BV) Test Kits Segment by Type
      • 2.2.1 Haemophilus Vaginitis
      • 2.2.2 Corynebacterium Vaginitis
      • 2.2.3 Anaerobic Vaginitis
      • 2.2.4 Gardnerella Vaginitis
      • 2.2.5 Others
      • 2.2.6 Bacterial Vaginosis (BV) Test Kits Sales by Type
        • 2.2.6.1 Global Bacterial Vaginosis (BV) Test Kits Sales Market Share by Type (2021-2026)
        • 2.2.6.2 Global Bacterial Vaginosis (BV) Test Kits Revenue and Market Share by Type (2021-2026)
        • 2.2.6.3 Global Bacterial Vaginosis (BV) Test Kits Sale Price by Type (2021-2026)
    • 2.3 Bacterial Vaginosis (BV) Test Kits Segment by Application
      • 2.3.1 Online Pharmacy
      • 2.3.2 Hospital
      • 2.3.3 Clinic
      • 2.3.4 Bacterial Vaginosis (BV) Test Kits Sales by Application
        • 2.3.4.1 Global Bacterial Vaginosis (BV) Test Kits Sale Market Share by Application (2021-2026)
        • 2.3.4.2 Global Bacterial Vaginosis (BV) Test Kits Revenue and Market Share by Application (2021-2026)
        • 2.3.4.3 Global Bacterial Vaginosis (BV) Test Kits Sale Price by Application (2021-2026)
  • 3 Global by Company

    • 3.1 Global Bacterial Vaginosis (BV) Test Kits Breakdown Data by Company
      • 3.1.1 Global Bacterial Vaginosis (BV) Test Kits Annual Sales by Company (2021-2026)
      • 3.1.2 Global Bacterial Vaginosis (BV) Test Kits Sales Market Share by Company (2021-2026)
    • 3.2 Global Bacterial Vaginosis (BV) Test Kits Annual Revenue by Company (2021-2026)
      • 3.2.1 Global Bacterial Vaginosis (BV) Test Kits Revenue by Company (2021-2026)
      • 3.2.2 Global Bacterial Vaginosis (BV) Test Kits Revenue Market Share by Company (2021-2026)
    • 3.3 Global Bacterial Vaginosis (BV) Test Kits Sale Price by Company
    • 3.4 Key Manufacturers Bacterial Vaginosis (BV) Test Kits Producing Area Distribution, Sales Area, Product Type
      • 3.4.1 Key Manufacturers Bacterial Vaginosis (BV) Test Kits Product Location Distribution
      • 3.4.2 Players Bacterial Vaginosis (BV) Test Kits Products Offered
    • 3.5 Market Concentration Rate Analysis
      • 3.5.1 Competition Landscape Analysis
      • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
    • 3.6 New Products and Potential Entrants
    • 3.7 Market M&A Activity & Strategy
  • 4 World Historic Review for Bacterial Vaginosis (BV) Test Kits by Geographic Region

    • 4.1 World Historic Bacterial Vaginosis (BV) Test Kits Market Size by Geographic Region (2021-2026)
      • 4.1.1 Global Bacterial Vaginosis (BV) Test Kits Annual Sales by Geographic Region (2021-2026)
      • 4.1.2 Global Bacterial Vaginosis (BV) Test Kits Annual Revenue by Geographic Region (2021-2026)
    • 4.2 World Historic Bacterial Vaginosis (BV) Test Kits Market Size by Country/Region (2021-2026)
      • 4.2.1 Global Bacterial Vaginosis (BV) Test Kits Annual Sales by Country/Region (2021-2026)
      • 4.2.2 Global Bacterial Vaginosis (BV) Test Kits Annual Revenue by Country/Region (2021-2026)
    • 4.3 Americas Bacterial Vaginosis (BV) Test Kits Sales Growth
    • 4.4 APAC Bacterial Vaginosis (BV) Test Kits Sales Growth
    • 4.5 Europe Bacterial Vaginosis (BV) Test Kits Sales Growth
    • 4.6 Middle East & Africa Bacterial Vaginosis (BV) Test Kits Sales Growth
  • 5 Americas

    • 5.1 Americas Bacterial Vaginosis (BV) Test Kits Sales by Country
      • 5.1.1 Americas Bacterial Vaginosis (BV) Test Kits Sales by Country (2021-2026)
      • 5.1.2 Americas Bacterial Vaginosis (BV) Test Kits Revenue by Country (2021-2026)
    • 5.2 Americas Bacterial Vaginosis (BV) Test Kits Sales by Type (2021-2026)
    • 5.3 Americas Bacterial Vaginosis (BV) Test Kits Sales by Application (2021-2026)
    • 5.4 United States
    • 5.5 Canada
    • 5.6 Mexico
    • 5.7 Brazil
  • 6 APAC

    • 6.1 APAC Bacterial Vaginosis (BV) Test Kits Sales by Region
      • 6.1.1 APAC Bacterial Vaginosis (BV) Test Kits Sales by Region (2021-2026)
      • 6.1.2 APAC Bacterial Vaginosis (BV) Test Kits Revenue by Region (2021-2026)
    • 6.2 APAC Bacterial Vaginosis (BV) Test Kits Sales by Type (2021-2026)
    • 6.3 APAC Bacterial Vaginosis (BV) Test Kits Sales by Application (2021-2026)
    • 6.4 China
    • 6.5 Japan
    • 6.6 South Korea
    • 6.7 Southeast Asia
    • 6.8 India
    • 6.9 Australia
    • 6.10 China Taiwan
  • 7 Europe

    • 7.1 Europe Bacterial Vaginosis (BV) Test Kits by Country
      • 7.1.1 Europe Bacterial Vaginosis (BV) Test Kits Sales by Country (2021-2026)
      • 7.1.2 Europe Bacterial Vaginosis (BV) Test Kits Revenue by Country (2021-2026)
    • 7.2 Europe Bacterial Vaginosis (BV) Test Kits Sales by Type (2021-2026)
    • 7.3 Europe Bacterial Vaginosis (BV) Test Kits Sales by Application (2021-2026)
    • 7.4 Germany
    • 7.5 France
    • 7.6 UK
    • 7.7 Italy
    • 7.8 Russia
  • 8 Middle East & Africa

    • 8.1 Middle East & Africa Bacterial Vaginosis (BV) Test Kits by Country
      • 8.1.1 Middle East & Africa Bacterial Vaginosis (BV) Test Kits Sales by Country (2021-2026)
      • 8.1.2 Middle East & Africa Bacterial Vaginosis (BV) Test Kits Revenue by Country (2021-2026)
    • 8.2 Middle East & Africa Bacterial Vaginosis (BV) Test Kits Sales by Type (2021-2026)
    • 8.3 Middle East & Africa Bacterial Vaginosis (BV) Test Kits Sales by Application (2021-2026)
    • 8.4 Egypt
    • 8.5 South Africa
    • 8.6 Israel
    • 8.7 Turkey
    • 8.8 GCC Countries
  • 9 Market Drivers, Challenges and Trends

    • 9.1 Market Drivers & Growth Opportunities
    • 9.2 Market Challenges & Risks
    • 9.3 Industry Trends
  • 10 Manufacturing Cost Structure Analysis

    • 10.1 Raw Material and Suppliers
    • 10.2 Manufacturing Cost Structure Analysis of Bacterial Vaginosis (BV) Test Kits
    • 10.3 Manufacturing Process Analysis of Bacterial Vaginosis (BV) Test Kits
    • 10.4 Industry Chain Structure of Bacterial Vaginosis (BV) Test Kits
  • 11 Marketing, Distributors and Customer

    • 11.1 Sales Channel
      • 11.1.1 Direct Channels
      • 11.1.2 Indirect Channels
    • 11.2 Bacterial Vaginosis (BV) Test Kits Distributors
    • 11.3 Bacterial Vaginosis (BV) Test Kits Customer
  • 12 World Forecast Review for Bacterial Vaginosis (BV) Test Kits by Geographic Region

    • 12.1 Global Bacterial Vaginosis (BV) Test Kits Market Size Forecast by Region
      • 12.1.1 Global Bacterial Vaginosis (BV) Test Kits Forecast by Region (2027-2032)
      • 12.1.2 Global Bacterial Vaginosis (BV) Test Kits Annual Revenue Forecast by Region (2027-2032)
    • 12.2 Americas Forecast by Country (2027-2032)
    • 12.3 APAC Forecast by Region (2027-2032)
    • 12.4 Europe Forecast by Country (2027-2032)
    • 12.5 Middle East & Africa Forecast by Country (2027-2032)
    • 12.6 Global Bacterial Vaginosis (BV) Test Kits Forecast by Type (2027-2032)
    • 12.7 Global Bacterial Vaginosis (BV) Test Kits Forecast by Application (2027-2032)
  • 13 Key Players Analysis

    • 13.1 Liming Bio
      • 13.1.1 Liming Bio Company Information
      • 13.1.2 Liming Bio Bacterial Vaginosis (BV) Test Kits Product Portfolios and Specifications
      • 13.1.3 Liming Bio Bacterial Vaginosis (BV) Test Kits Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.1.4 Liming Bio Main Business Overview
      • 13.1.5 Liming Bio Latest Developments
    • 13.2 Exeltis USA Inc
      • 13.2.1 Exeltis USA Inc Company Information
      • 13.2.2 Exeltis USA Inc Bacterial Vaginosis (BV) Test Kits Product Portfolios and Specifications
      • 13.2.3 Exeltis USA Inc Bacterial Vaginosis (BV) Test Kits Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.2.4 Exeltis USA Inc Main Business Overview
      • 13.2.5 Exeltis USA Inc Latest Developments
    • 13.3 Sekisui Diagnostics
      • 13.3.1 Sekisui Diagnostics Company Information
      • 13.3.2 Sekisui Diagnostics Bacterial Vaginosis (BV) Test Kits Product Portfolios and Specifications
      • 13.3.3 Sekisui Diagnostics Bacterial Vaginosis (BV) Test Kits Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.3.4 Sekisui Diagnostics Main Business Overview
      • 13.3.5 Sekisui Diagnostics Latest Developments
    • 13.4 Bayer
      • 13.4.1 Bayer Company Information
      • 13.4.2 Bayer Bacterial Vaginosis (BV) Test Kits Product Portfolios and Specifications
      • 13.4.3 Bayer Bacterial Vaginosis (BV) Test Kits Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.4.4 Bayer Main Business Overview
      • 13.4.5 Bayer Latest Developments
    • 13.5 Hologic
      • 13.5.1 Hologic Company Information
      • 13.5.2 Hologic Bacterial Vaginosis (BV) Test Kits Product Portfolios and Specifications
      • 13.5.3 Hologic Bacterial Vaginosis (BV) Test Kits Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.5.4 Hologic Main Business Overview
      • 13.5.5 Hologic Latest Developments
    • 13.6 AccuQuik
      • 13.6.1 AccuQuik Company Information
      • 13.6.2 AccuQuik Bacterial Vaginosis (BV) Test Kits Product Portfolios and Specifications
      • 13.6.3 AccuQuik Bacterial Vaginosis (BV) Test Kits Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.6.4 AccuQuik Main Business Overview
      • 13.6.5 AccuQuik Latest Developments
    • 13.7 AtilaBiosystems
      • 13.7.1 AtilaBiosystems Company Information
      • 13.7.2 AtilaBiosystems Bacterial Vaginosis (BV) Test Kits Product Portfolios and Specifications
      • 13.7.3 AtilaBiosystems Bacterial Vaginosis (BV) Test Kits Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.7.4 AtilaBiosystems Main Business Overview
      • 13.7.5 AtilaBiosystems Latest Developments
  • 14 Research Findings and Conclusion

USD 7,320 or Partial Purchase
*Prices are subject to change by the publisher.
© 2026 ShareFair Inc.